Radiation Oncology ECHO - Recurrence Endometrial cancer with squamous differentiation

Description

Radiation oncologist experts provide advice for patient case on recurrent endometrial cancer presented by Dr. Nanise Sikiti of Fiji. Session will include case presentation, distillation, panel discussion, and Q&A.

Thursday, April 27, 2023, 11:00 AM UTC
Duration approximately 60 minutes

The ECHO is available only for IGCS member's as part of member benefits. The ECHO will be recorded and available for IGCS members.
If you are not a member of IGCS, we invite you to join today, see additional membership information below.

To register, please log into your already existing IGCS member account. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

Faculty Information

Moderator: Hannah Simonds (United Kingdom)
Case Presenter: Nanise Sikiti (Fiji)
Distillation: Pearly Khaw (Australia)
Panelists: Alexandra Taylor (United Kingdom)

IGCS Membership Information

Not an IGCS member? Join IGCS today and be a part of the leading global society advancing gynecologic cancer care around the world. In addition to complimentary valuable educational resources and training opportunities, you will also be supporting the society’s mission to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness. Click here to learn more about IGCS member benefits.

Summary

Availability:

No future session

Cost:

FREE

Create Account

Recommended

Radiation Oncology ECHO - Carcinoma Cervix With Nodal Metastasis - Management Challenges

Radiation oncologist experts provide advice for patient case presented by Dr. Vinita Thampy of India. Utilizing the Project ECHO® Virtual Tumor Board format, the recording includes a case presentation, distillation, panel discussion, and Q&A.

Free

International Gynecologic Cancer Society and International Journal of Gynecological Cancer Evidence-Based Medicine for Gynecological Oncology Curriculum (EBM on the GO)

Evidence based medicine (EBM) is defined as the process of systematically finding, appraising, and applying current research to make clinical decisions. EBM integrates clinical expertise with the best available evidence and patients’ values & preferences.

Free

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.

Free

Surgical Film Library

Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.

Free

Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer

This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.

Free

Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm

Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.

Free

Uterine Cancers in the Molecular Era: Changing Trends and Implications

This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.

Free

IGCS 2024 Endometrial Cancer Master Session

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free

From Data to Practice: Integrating Key Phase III Results into Ovarian Cancer Management

Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.

Free

Malignant Bowel Obstruction in Gynecologic Cancers Podcast Series

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care.

Free